In sum, our findings show that Gö6976 treatment potentiates antitumor effect of ATRA by inducing apoptosis of breast cancer cells, inhibiting cancer stem cell self-renewal and clonogenicity and leading to RARs balance compatible with an anti-oncogenic response. The gene discussed is RARS1; the disease is cancer.